On the public citation graph

Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implications

0 signed · 250 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.1990.03440180133052openalex-snapshot
The Metabolic Basis of Inherited Disease
inferredcites →https://doi.org/10.1002/(sici)1098-1004(1996)7:1<23::aid-humu3>3.0.co;2-qopenalex-snapshot
Mucopolysaccharidosis type I: Identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations
inferredcites →https://doi.org/10.1002/ajmg.1320280136openalex-snapshot
A nonpathologic allele (IW) for low α‐L‐iduronidase enzyme activity vis‐a‐vis prenatal diagnosis of Hurler syndrome
inferredcites →https://doi.org/10.1002/ajmg.1320470732openalex-snapshot
Intrafamilial variability in Hurler syndrome and Sanfilippo syndrome type A: Implications for evaluation of new therapies
inferredcites →https://doi.org/10.1002/humu.1380010104openalex-snapshot
Molecular basis of phenylketonuria and related hyperphenylalaninemias: Mutations and polymorphisms in the human phenylalanine hydroxylase gene
inferredcites →https://doi.org/10.1002/humu.1380010204openalex-snapshot
A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype
inferredcites →https://doi.org/10.1002/humu.1380010412openalex-snapshot
α-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype
inferredcites →https://doi.org/10.1002/humu.1380020113openalex-snapshot
A deletion/insertion mutation in theIDUA gene in a Libyan Jewish patient with Hurler syndrome (mucopolysaeeharidosis IH)
inferredcites →https://doi.org/10.1002/humu.1380020215openalex-snapshot
Mutation in Scheie syndrome (MPS IS): A G→A transition creates new splice site in intron 5 of one IDUA allele
inferredcites →https://doi.org/10.1002/humu.1380020603openalex-snapshot
Molecular basis of mucopolysaccharidosis type II: Mutations in the iduronate-2-sulphatase gene
inferredcites →https://doi.org/10.1002/humu.1380030316openalex-snapshot
Mutation analysis of 19 North American mucopolysaccharidosis type I patients: Identification of two additional frequent mutations
inferredcites →https://doi.org/10.1002/humu.1380030330openalex-snapshot
A mutant stop codon (TAG) in the IDUA gene is used as an acceptor splice site in a patient with Hurler syndrome (MPS IH)
inferredcites →https://doi.org/10.1002/humu.1380060111openalex-snapshot
Four novel mutations underlying mild or intermediate forms of α-L-iduronidase deficiency (MPS IS and MPS IH/S)
inferredcites →https://doi.org/10.1002/humu.1380060119openalex-snapshot
Mucopolysaccharidosis type I: Identification of 13 novel mutations of the α-L-iduronidase gene
inferredcites →https://doi.org/10.1002/pd.1970050209openalex-snapshot
Prenatal diagnosis of mucopolysaccharidosis I: A special difficulty arising from an unusually low enzyme activity in mother's cells
inferredcites →https://doi.org/10.1006/geno.1994.1621openalex-snapshot
Murine α-l-Iduronidase: cDNA Isolation and Expression
inferredcites →https://doi.org/10.1006/prep.1994.1035openalex-snapshot
Overexpression of the Human Lysosomal Enzyme α-L-Iduronidase in Chinese Hamster Ovary Cells
inferredcites →https://doi.org/10.1007/bf00206770openalex-snapshot
An update on the frequency of mucopolysaccharide syndromes in British Columbia
inferredcites →https://doi.org/10.1007/bf00220095openalex-snapshot
PCR detection of two RFLPs in exon I of the ?-L-iduronidase (IDUA) gene
inferredcites →https://doi.org/10.1007/bf00711517openalex-snapshot
Diagnosis and prevention of lysosomal storage diseases in Russia
inferredcites →https://doi.org/10.1007/bf00711520openalex-snapshot
Long‐term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype
inferredcites →https://doi.org/10.1007/bf00711533openalex-snapshot
Pseudodeficiency of α‐iduronidase
inferredcites →https://doi.org/10.1007/bf01233067openalex-snapshot
Huntington disease-linked locusD4S111 exposed as the ?-l-iduronidase gene
inferredcites →https://doi.org/10.1007/bf02222956openalex-snapshot
Über einen Typ multipler Abartungen, vorwiegend am Skelettsystem
inferredcites →https://doi.org/10.1007/bf02265303openalex-snapshot
Mucopolysaccharidosis type I (Hurler syndrome): Linkage disequilibrium indicates the presence of a major allele
inferredcites →https://doi.org/10.1016/0002-9394(62)91975-xopenalex-snapshot
Filtering Operations for Glaucoma: A Comparative Study
inferredcites →https://doi.org/10.1016/0022-2836(91)90528-eopenalex-snapshot
Suggestions for “safe” residue substitutions in site-directed mutagenesis
inferredcites →https://doi.org/10.1016/0092-8674(94)90302-6openalex-snapshot
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
inferredcites →https://doi.org/10.1016/0885-4505(92)90028-wopenalex-snapshot
Hurler syndrome: A patient with abnormally high levels of α-l-iduronidase protein
inferredcites →https://doi.org/10.1016/0888-7543(91)90039-hopenalex-snapshot
Identification of multiple CpG islands and associated conserved sequences in a candidate region for the Huntington disease gene
inferredcites →https://doi.org/10.1016/0888-7543(92)90053-uopenalex-snapshot
Structure and sequence of the human α-l-iduronidase gene
inferredcites →https://doi.org/10.1016/b978-1-4377-0435-8.00036-6openalex-snapshot
Lysosomal Storage Diseases
inferredcites →https://doi.org/10.1016/s0021-9258(19)50465-3openalex-snapshot
Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog.
inferredcites →https://doi.org/10.1016/s0140-6736(72)91159-2openalex-snapshot
ALLELISM, NON-ALLELISM, AND GENETIC COMPOUNDS AMONG THE MUCOPOLYSACCHARIDOSES
inferredcites →https://doi.org/10.1016/s0888-7543(05)80145-4openalex-snapshot
An 86-bp VNTR within IDUA is the basis of the D4S111 polymorphic locus
inferredcites →https://doi.org/10.1016/s0888-7543(05)80182-xopenalex-snapshot
Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I
inferredcites →https://doi.org/10.1038/ng1193-274openalex-snapshot
A mutation in CFTR produces different phenotypes depending on chromosomal background
inferredcites →https://doi.org/10.1042/bj2590199openalex-snapshot
Immunopurification and characterization of human α- l -iduronidase with the use of monoclonal antibodies
inferredcites →https://doi.org/10.1042/bj3040043openalex-snapshot
Recombinant α- l -iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts
inferredcites →https://doi.org/10.1073/pnas.69.8.2048openalex-snapshot
The Defect in the Hurler and Scheie Syndromes: Deficiency of α-L-Iduronidase
inferredcites →https://doi.org/10.1073/pnas.88.21.9695openalex-snapshot
Human alpha-L-iduronidase: cDNA isolation and expression.
inferredcites →https://doi.org/10.1073/pnas.91.26.12937openalex-snapshot
Enzyme replacement in a canine model of Hurler syndrome.
inferredcites →https://doi.org/10.1089/hum.1992.3.4-371openalex-snapshot
Correction of Mucopolysaccharidosis Type I Fibroblasts by Retroviral-Mediated Transfer of the Human α- l -Iduronidase Gene
inferredcites →https://doi.org/10.1093/hmg/2.8.1311openalex-snapshot
Two novel mutations causing mucopolysaccharidosis type I detected by single strand conformational analysis of the α-L-iduronidase gene
inferredcites →https://doi.org/10.1093/hmg/2.9.1471openalex-snapshot
Multiple polymorphisms within the α-L-iduronidase gene (IDUA): implications for a role in modification of MPS-I disease phenotype
inferredcites →https://doi.org/10.1093/hmg/3.6.861openalex-snapshot
Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common α-L-iduronidase mutations (W402X and Q70X) among European patients
inferredcites →https://doi.org/10.1093/milmed/138.8.503bopenalex-snapshot
Heritable Disorders of Connective Tissue
inferredcites →https://doi.org/10.1093/nar/14.11.4683openalex-snapshot
A new method for predicting signal sequence cleavage sites
inferredcites →https://doi.org/10.1093/nar/19.20.5796-aopenalex-snapshot
PCR of a Kpnl RFLP in the α-L-iduronidase (IDUA) gene
inferredcites →https://doi.org/10.1093/nar/19.22.6348-aopenalex-snapshot
PCR of a VNTR linked to mucopolysaccharidosis type I and Huntington disease
inferredcites →https://doi.org/10.1099/00221287-139-6-1235openalex-snapshot
Genetic organization, sequence and biochemical characterization of recombinant -xylosidase from Thermoanaerobacterium saccharolyticum strain B6A-RI
inferredcites →https://doi.org/10.1126/science.169.3940.72openalex-snapshot
Scheie and Hurler Syndromes: Apparent Identity of the Biochemical Defect
inferredcites →https://doi.org/10.1128/aem.56.4.1017-1024.1990openalex-snapshot
Cloning, sequence analysis, and expression of genes encoding xylan-degrading enzymes from the thermophile "Caldocellum saccharolyticum"
inferredcites →https://doi.org/10.1136/jcp.36.8.961-bopenalex-snapshot
The Metabolic Basis of Inherited Disease
inferredcites →https://doi.org/10.1146/annurev.bi.60.070191.001353openalex-snapshot
LYSOSOMAL STORAGE DISEASES
inferredcites →https://doi.org/10.1159/000112332openalex-snapshot
Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological Disorders

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3988395openalex-extracted
Targeted Pseudouridylation: A Novel Approach for Suppressing Nonsense Mutations in Disease Genes
inferred← citeshttps://doi.org/10.2139/ssrn.4773584openalex-extracted
Targeted Pseudouridylation Identifies a Novel Ψ-Ψ Codon-Anticodon Pairing in Nonsense Suppression and Translational Recoding
inferred← citeshttps://doi.org/10.1002/(sici)1096-8628(20000117)90:2<108::aid-ajmg3>3.0.co;2-yopenalex-snapshot
Unique frequency of known mutations in Brazilian MPS I patients
inferred← citeshttps://doi.org/10.1002/(sici)1098-1004(1997)10:6<479::aid-humu10>3.0.co;2-xopenalex-snapshot
Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A)
inferred← citeshttps://doi.org/10.1002/(sici)1098-1004(1998)11:4<332::aid-humu16>3.0.co;2-popenalex-snapshot
Analysis of five mutations in 20 mucopolysaccharidosis type I patients: High prevalence of the W402X mutation
inferred← citeshttps://doi.org/10.1002/14651858.cd009354openalex-snapshot
Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1002/14651858.cd009354.pub4openalex-snapshot
Enzyme replacement therapy with laronidase (Aldurazyme® ) for treating mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1002/9780470987070.ch107openalex-snapshot
Hematopoietic Cell Transplantation for Storage Diseases
inferred← citeshttps://doi.org/10.1002/9781118981559.ch22openalex-snapshot
Prenatal Diagnosis of the Mucopolysaccharidoses and Postnatal Enzyme Replacement Therapy
inferred← citeshttps://doi.org/10.1002/9781444314342.ch14openalex-snapshot
Prenatal Diagnosis of the Mucopolysaccharidoses and Postnatal Enzyme Replacement Therapy
inferred← citeshttps://doi.org/10.1002/ajmg.a.32812openalex-snapshot
Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C‐terminus of the IDUA protein
inferred← citeshttps://doi.org/10.1002/ccr3.5904openalex-snapshot
Alpha‐L‐iduronidase deficiency: A novel mutation resulting in severe early presentation of Mucopolysaccharidosis type I and literature review of the molecular basis
inferred← citeshttps://doi.org/10.1002/eji.200939639openalex-snapshot
Development and maturation of invariant NKT cells in the presence of lysosomal engulfment
inferred← citeshttps://doi.org/10.1002/humu.1190openalex-snapshot
Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase
inferred← citeshttps://doi.org/10.1002/humu.20081openalex-snapshot
Identification and molecular characterization of α-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy
inferred← citeshttps://doi.org/10.1002/humu.21093openalex-snapshot
Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy
inferred← citeshttps://doi.org/10.1002/humu.23301openalex-snapshot
IDUA mutational profile and genotype–phenotype relationships in UK patients with Mucopolysaccharidosis Type I
inferred← citeshttps://doi.org/10.1002/humu.9051openalex-snapshot
Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations
inferred← citeshttps://doi.org/10.1002/jbmr.2290openalex-snapshot
Effects of Neonatal Enzyme Replacement Therapy and Simvastatin Treatment on Cervical Spine Disease in Mucopolysaccharidosis I Dogs
inferred← citeshttps://doi.org/10.1002/jimd.12316openalex-snapshot
Novel therapies for mucopolysaccharidosis type III
inferred← citeshttps://doi.org/10.1002/mgg3.1058openalex-snapshot
Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree
inferred← citeshttps://doi.org/10.1002/mgg3.615openalex-snapshot
“Missing mutations” in MPS I: Identification of two novel copy number variations by an IDUA ‐specific in house MLPA assay
inferred← citeshttps://doi.org/10.1007/3-540-27660-2_13openalex-snapshot
Mucoplysaccharidoses
inferred← citeshttps://doi.org/10.1007/8904_2015_485openalex-snapshot
Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity
inferred← citeshttps://doi.org/10.1007/978-0-387-68979-1_7openalex-snapshot
Hereditary Optic Neuropathies
inferred← citeshttps://doi.org/10.1007/978-0-387-70909-3_24openalex-snapshot
Mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.1007/978-1-4614-0691-4_7openalex-snapshot
Hereditary Optic Neuropathies
inferred← citeshttps://doi.org/10.1007/978-1-4614-1037-9_161openalex-snapshot
Mucopolysaccharidosis I (MPS I)
inferred← citeshttps://doi.org/10.1007/978-1-4614-6430-3_161-2openalex-snapshot
Mucopolysaccharidosis I (MPS I)
inferred← citeshttps://doi.org/10.1007/978-1-4614-8357-1_4openalex-snapshot
Leukodystrophies and Lysosomal Storage Disorders
inferred← citeshttps://doi.org/10.1007/978-1-4615-4887-4_11openalex-snapshot
Lysosomal Disorders
inferred← citeshttps://doi.org/10.1007/978-1-4615-4889-8_7openalex-snapshot
Gene Therapy for Lysosomal Disorders
inferred← citeshttps://doi.org/10.1007/978-1-4939-2401-1_161openalex-snapshot
Mucopolysaccharidosis I (MPS I)
inferred← citeshttps://doi.org/10.1007/978-1-60327-161-5_128openalex-snapshot
Mucopolysaccharidosis I (MPS I) (α-L-Iduronidase Deficiency): Hurler (MPS I-H), Hurler-Scheie (MPS I-H/S), and Scheie (MPS I-S) Syndromes
inferred← citeshttps://doi.org/10.1007/978-3-319-24085-5_10openalex-snapshot
Hereditary Optic Neuropathies
inferred← citeshttps://doi.org/10.1007/978-3-642-02202-9_39openalex-snapshot
Lysosomal Storage Diseases
inferred← citeshttps://doi.org/10.1007/978-3-642-56944-9_10openalex-snapshot
Das Herz bei Stoffwechselerkrankungen
inferred← citeshttps://doi.org/10.1007/978-3-662-09176-0_34openalex-snapshot
Heteroglykanosen
inferred← citeshttps://doi.org/10.1007/978-3-662-12660-8_6openalex-snapshot
Stoffwechselkrankheiten
inferred← citeshttps://doi.org/10.1007/bf00208355openalex-snapshot
A clinically mild case of mucopolysaccharidosis type I ?Scheie syndrome (case report)
inferred← citeshttps://doi.org/10.1007/s00112-004-0965-5openalex-snapshot
Blutstammzelltransplantation bei Mukopolysaccharidose Typ 1H (Morbus Hurler)
inferred← citeshttps://doi.org/10.1007/s002470050153openalex-snapshot
Osteochondrodysplasias, dysostoses, disorders of calcium metabolism, congenital malformations with skeletal involvement mapped on human chromosomes
inferred← citeshttps://doi.org/10.1007/s004390100606openalex-snapshot
Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations
inferred← citeshttps://doi.org/10.1007/s10038-008-0272-4openalex-snapshot
Structural study on mutant α-l-iduronidases: insight into mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1007/s10545-005-0197-4openalex-snapshot
Mucopolysaccharidosis I: α‐ L ‐Iduronidase mutations in three Tunisian families
inferred← citeshttps://doi.org/10.1007/s10545-009-1265-yopenalex-snapshot
Scheie syndrome: Enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression
inferred← citeshttps://doi.org/10.1007/s10545-010-9130-6openalex-snapshot
Newborn screening for neuropathic lysosomal storage disorders
inferred← citeshttps://doi.org/10.1007/s11103-017-0673-xopenalex-snapshot
N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-l-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.1007/s11427-016-5090-xopenalex-snapshot
Regulation of lysosomal ion homeostasis by channels and transporters
inferred← citeshttps://doi.org/10.1007/s40142-026-00246-5openalex-snapshot
Molecular Genetic Investigation of Mucopolysaccharidosis 1 Disease in 10 Patients from Unrelated Pakistani Families
inferred← citeshttps://doi.org/10.1016/b978-0-323-99417-0.00002-1openalex-snapshot
Neuronopathic lysosomal storage disorders
inferred← citeshttps://doi.org/10.1016/b978-0-443-11851-7.00071-9openalex-snapshot
Cardiovascular Aspects of Systemic Disease
inferred← citeshttps://doi.org/10.1016/b978-0-7020-3064-2.00061-8openalex-snapshot
Cardiological Aspects of Systemic Disease
inferred← citeshttps://doi.org/10.1016/b978-008044859-6/50011-3openalex-snapshot
Lysosomal Degradation of Heparin and Heparan Sulfate
inferred← citeshttps://doi.org/10.1016/b978-1-4160-2447-7.50076-1openalex-snapshot
MUCOPOLYSACCHARIDOSIS IH 277.5 (Dysostosis Multiplex, Hurler Syndrome, MPS IH, Pfaundler–Hurler Syndrome)
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3435-3.50019-1openalex-snapshot
Oral Manifestations of Systemic Diseases
inferred← citeshttps://doi.org/10.1016/b978-3-437-23064-6.00033-2openalex-snapshot
Skoliose und Anomalien mit generalisierter Beteiligung des Skeletts
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2022.06.001openalex-snapshot
Translation termination codons in protein synthesis and disease
inferred← citeshttps://doi.org/10.1016/j.ajhg.2026.09.008openalex-snapshot
Hypomorphic IDUA genotypes are associated with retinitis pigmentosa in individuals without syndromic mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1016/j.arcped.2007.06.018openalex-snapshot
La mucopolysaccharidose de type I: identification des mutations du gène alpha-L-iduronidase dans des familles tunisiennes
inferred← citeshttps://doi.org/10.1016/j.bbrc.2022.10.081openalex-snapshot
Effects of gentamicin inducing readthrough premature stop Codons: A study of alpha-L-iduronidase nonsense variants in COS-7 Cells
inferred← citeshttps://doi.org/10.1016/j.bone.2013.03.014openalex-snapshot
Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs
inferred← citeshttps://doi.org/10.1016/j.bone.2021.116237openalex-snapshot
Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs
inferred← citeshttps://doi.org/10.1016/j.brainres.2006.01.008openalex-snapshot
Long-term memory for aversive training is impaired in Idua−/− mice, a genetic model of mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1016/j.cca.2009.11.027openalex-snapshot
Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of α-l-iduronidase mutations causing mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1016/j.cca.2013.01.009openalex-snapshot
Mucopolysaccharidosis type IIIB mutations in Chinese patients: Identification of two novel NAGLU mutations and analysis of two cases involving prenatal diagnosis
inferred← citeshttps://doi.org/10.1016/j.cca.2021.11.019openalex-snapshot
Molecular analysis and novel variation identification of Chinese pedigrees with mucopolysaccharidosis using targeted next-generation sequencing
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2020.12.002openalex-snapshot
Lysosomal storage disorders: Novel and frequent pathogenic variants in a large cohort of Indian patients of Pompe, Fabry, Gaucher and Hurler disease
inferred← citeshttps://doi.org/10.1016/j.cxom.2014.05.005openalex-snapshot
Metabolic and Autoimmune Syndromes
inferred← citeshttps://doi.org/10.1016/j.genrep.2019.100488openalex-snapshot
An ultra-rare mutation (C.181C>T) in GALNS gene associated with Morquio syndrome: A case report
inferred← citeshttps://doi.org/10.1016/j.glycos.2026.100036openalex-snapshot
Advances in glycosaminoglycan based diagnostic strategies for mucopolysaccharidoses
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e07740openalex-snapshot
Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation
inferred← citeshttps://doi.org/10.1016/j.jid.2019.04.023openalex-snapshot
Quantitative Trait Locus and Integrative Genomics Revealed Candidate Modifier Genes for Ectopic Mineralization in Mouse Models of Pseudoxanthoma Elasticum
inferred← citeshttps://doi.org/10.1016/j.jmb.2004.03.012openalex-snapshot
α-l-Iduronidase Premature Stop Codons and Potential Read-Through in Mucopolysaccharidosis Type I Patients
inferred← citeshttps://doi.org/10.1016/j.jns.2010.11.022openalex-snapshot
Cervical pachymeningeal hypertrophy as the initial and cardinal manifestation of mucopolysaccharidosis type I in monozygotic twins with a novel mutation in the alpha-l-iduronidase gene
inferred← citeshttps://doi.org/10.1016/j.mattod.2025.06.020openalex-snapshot
Aptamers in drug delivery development
inferred← citeshttps://doi.org/10.1016/j.mehy.2003.12.027openalex-snapshot
A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses
inferred← citeshttps://doi.org/10.1016/j.molcel.2023.01.009openalex-snapshot
Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes
inferred← citeshttps://doi.org/10.1016/j.molmed.2006.06.001openalex-snapshot
Stop-codon read-through for patients affected by a lysosomal storage disorder
inferred← citeshttps://doi.org/10.1016/j.ymgme.2004.09.004openalex-snapshot
Prediction of neuropathology in mucopolysaccharidosis I patients
inferred← citeshttps://doi.org/10.1016/j.ymgme.2007.01.011openalex-snapshot
The MPS I registry: Design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I
inferred← citeshttps://doi.org/10.1016/j.ymgme.2009.08.002openalex-snapshot
Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation
inferred← citeshttps://doi.org/10.1016/j.ymgme.2011.07.012openalex-snapshot
A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants
inferred← citeshttps://doi.org/10.1016/j.ymgme.2013.05.016openalex-snapshot
Residual α-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients
inferred← citeshttps://doi.org/10.1016/j.ymgme.2013.10.005openalex-snapshot
Structural and clinical implications of amino acid substitutions in α-l-iduronidase: Insight into the basis of mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1016/j.ymgme.2013.11.014openalex-snapshot
Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler–Scheie syndrome
inferred← citeshttps://doi.org/10.1016/j.ymgmr.2017.06.001openalex-snapshot
Novel frameshift variant in the IDUA gene underlies Mucopolysaccharidoses type I in a consanguineous Yemeni pedigree
inferred← citeshttps://doi.org/10.1016/j.ymthe.2004.03.011openalex-snapshot
Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human α-l-iduronidase gene
inferred← citeshttps://doi.org/10.1016/j.ymthe.2006.03.015openalex-snapshot
Mucopolysaccharidosis I Cats Mount a Cytotoxic T Lymphocyte Response after Neonatal Gene Therapy That Can Be Blocked with CTLA4-Ig
inferred← citeshttps://doi.org/10.1016/j.ymthe.2019.04.014openalex-snapshot
Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease
inferred← citeshttps://doi.org/10.1016/s0002-9149(01)01999-3openalex-snapshot
Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the hurler syndrome
inferred← citeshttps://doi.org/10.1016/s0002-9149(03)00909-3openalex-snapshot
Usefulness of bone marrow transplantation in the Hurler syndrome
inferred← citeshttps://doi.org/10.1016/s0002-9440(10)63103-3openalex-snapshot
Retrovirally Mediated Overexpression of Versican V3 Reverses Impaired Elastogenesis and Heightened Proliferation Exhibited by Fibroblasts from Costello Syndrome and Hurler Disease Patients
inferred← citeshttps://doi.org/10.1016/s0002-9440(10)64961-9openalex-snapshot
Impaired Elastogenesis in Hurler Disease
inferred← citeshttps://doi.org/10.1016/s0009-8981(01)00593-9openalex-snapshot
Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma α-l-iduronidase
inferred← citeshttps://doi.org/10.1016/s0009-8981(01)00811-7openalex-snapshot
Effect of CuCl2, NaCl and EDTA on the enzyme α-l-iduronidase in the plasma of normal individuals and heterozygotes for MPS I
inferred← citeshttps://doi.org/10.1016/s0022-3476(98)70201-xopenalex-snapshot
Follow-up of nine patients with Hurler syndrome after bone marrow transplantation
inferred← citeshttps://doi.org/10.1016/s0167-4781(01)00267-6openalex-snapshot
The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein
inferred← citeshttps://doi.org/10.1016/s0181-5512(07)89568-4openalex-snapshot
Un point d’appel ophtalmologique à l’origine du diagnostic de deux cas de mucopolysaccharidose
inferred← citeshttps://doi.org/10.1016/s0188-4409(01)00334-4openalex-snapshot
Detection of Mucopolysaccharidosis Type I Heterozygotes Based on the Biochemical Characteristics of Leukocyte α-L-Iduronidase
inferred← citeshttps://doi.org/10.1016/s0888-7543(02)00014-9openalex-snapshot
Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase
inferred← citeshttps://doi.org/10.1016/s0925-4439(03)00129-7openalex-snapshot
The α-l-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation
inferred← citeshttps://doi.org/10.1016/s0925-4439(98)00046-5openalex-snapshot
Genotype–phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies
inferred← citeshttps://doi.org/10.1016/s0929-693x(14)72255-9openalex-snapshot
Génétique des mucopolysaccharidoses
inferred← citeshttps://doi.org/10.1016/s1096-7192(02)00200-7openalex-snapshot
Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
inferred← citeshttps://doi.org/10.1016/s1096-7192(03)00116-1openalex-snapshot
Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow
inferred← citeshttps://doi.org/10.1016/s1472-6483(10)60864-4openalex-snapshot
First pregnancy and life after preimplantation genetic diagnosis by polar body analysis for mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1023/a:1005525931994openalex-snapshot
Long‐term follow‐up following bone marrow transplantation for Hunter disease
inferred← citeshttps://doi.org/10.1023/a:1012419823739openalex-snapshot
Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?
inferred← citeshttps://doi.org/10.1034/j.1399-0004.1999.560109.xopenalex-snapshot
Mucopolysaccharidosis type I: Characterization of novel mutations affecting α‐ l ‐iduronidase activity
inferred← citeshttps://doi.org/10.1034/j.1399-0004.2000.570207.xopenalex-snapshot
Identification and characterization of ‐3c–g acceptor splice site mutation in human α‐ l ‐iduronidase associated with mucopolysaccharidosis type IH/S
inferred← citeshttps://doi.org/10.1034/j.1399-0004.2001.600513.xopenalex-snapshot
The frequency of common mutations among patients with mucopolysaccharidosis types I, II and IIIA diagnosed in Austria over the last 17 years
inferred← citeshttps://doi.org/10.1038/bmt.2009.319openalex-snapshot
Pre-transplant risk factors affecting outcome in Hurler syndrome
inferred← citeshttps://doi.org/10.1038/gt.2013.14openalex-snapshot
Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice
inferred← citeshttps://doi.org/10.1038/mtm.2014.68openalex-snapshot
A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1038/sj.bmt.1704105openalex-snapshot
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources
inferred← citeshttps://doi.org/10.1038/sj.bmt.1704786openalex-snapshot
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler)
inferred← citeshttps://doi.org/10.1046/j.1432-1033.2002.02951.xopenalex-snapshot
In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors
inferred← citeshttps://doi.org/10.1046/j.1523-1747.2002.19637.xopenalex-snapshot
Progress in Molecular Genetics of Heritable Skin Diseases: The Paradigms of Epidermolysis Bullosa and Pseudoxanthoma Elasticum
inferred← citeshttps://doi.org/10.1055/s-0039-1685190openalex-snapshot
A Novel Frameshift Mutation Associated with Hurler's Syndrome: A Case Report
inferred← citeshttps://doi.org/10.1056/nejm200101183440304openalex-snapshot
Enzyme-Replacement Therapy in Mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.1074/jbc.272.36.22758openalex-snapshot
Carbohydrate Structures of Recombinant Human α-l-Iduronidase Secreted by Chinese Hamster Ovary Cells
inferred← citeshttps://doi.org/10.1080/08035250510031584openalex-snapshot
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1080/13816810.2025.2536658openalex-snapshot
Honoring Professor Andreas Gal
inferred← citeshttps://doi.org/10.1080/21678707.2020.1715208openalex-snapshot
The potential of gene therapy for mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.1089/104303402760372918openalex-snapshot
In Utero Injection of α -L-Iduronidase-Carrying Retrovirus in Canine Mucopolysaccharidosis Type I: Infection of Multiple Tissues and Neonatal Gene Expression
inferred← citeshttps://doi.org/10.1089/10430349950017158openalex-snapshot
Enzymatic Correction and Cross-Correction of Mucopolysaccharidosis Type I Fibroblasts by Adeno-Associated Virus-Mediated Transduction of the alpha-L-Iduronidase Gene
inferred← citeshttps://doi.org/10.1089/10430349950017851openalex-snapshot
Gene Therapy for Canine alpha-L-Iduronidase Deficiency: In Utero Adoptive Transfer of Genetically Corrected Hematopoietic Progenitors Results in Engraftment but Not Amelioration of Disease
inferred← citeshttps://doi.org/10.1089/gtmb.2009.0057openalex-snapshot
Mutational Analysis of the α-L-Iduronidase Gene in Three Egyptian Families: Identification of Three Novel Mutations and Five Novel Polymorphisms
inferred← citeshttps://doi.org/10.1089/hum.1996.7.13-1595openalex-snapshot
Myoblast Gene Therapy in Canine Mucopolysaccharidosis I: Abrogation by an Immune Response to α - l -Iduronidase
inferred← citeshttps://doi.org/10.1089/hum.2005.16.81openalex-snapshot
Gene Therapy for a Mucopolysaccharidosis Type I Murine Model with Lentiviral-IDUA Vector
inferred← citeshttps://doi.org/10.1089/hum.2017.187openalex-snapshot
Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
inferred← citeshttps://doi.org/10.1093/acprof:oso/9780198508786.003.0004openalex-snapshot
Primary defects in lysosomal enzymes
inferred← citeshttps://doi.org/10.1093/glycob/11.9.741openalex-snapshot
Glycosidase active site mutations in human -L-iduronidase
inferred← citeshttps://doi.org/10.1093/hmg/6.4.503openalex-snapshot
Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene
inferred← citeshttps://doi.org/10.1093/hmg/6.9.1573openalex-snapshot
Novel mutations in Sanfilippo A syndrome: implications for enzyme function
inferred← citeshttps://doi.org/10.1093/hmg/ddy259openalex-snapshot
Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.1093/rheumatology/ker394openalex-snapshot
Overview of the mucopolysaccharidoses
inferred← citeshttps://doi.org/10.1097/00125817-200211000-00004openalex-snapshot
Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human α-l-iduronidase (IDUA) gene
inferred← citeshttps://doi.org/10.1097/01.gim.0000078027.83236.49openalex-snapshot
Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literature
inferred← citeshttps://doi.org/10.1107/s1744309112040432openalex-snapshot
Crystallization, X-ray diffraction analysis and SIRAS phasing of human α- L -iduronidase
inferred← citeshttps://doi.org/10.1111/age.13015openalex-snapshot
Resequencing and signatures of selection scan in two Siberian native sheep breeds point to candidate genetic variants for adaptation and economically important traits
inferred← citeshttps://doi.org/10.1111/ahg.12236openalex-snapshot
p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS‐7 cells
inferred← citeshttps://doi.org/10.1111/cge.13583openalex-snapshot
Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry
inferred← citeshttps://doi.org/10.1111/echo.13444openalex-snapshot
Myocardial deformation in pediatric patients with mucopolysaccharidoses: A two‐dimensional speckle tracking echocardiography study
inferred← citeshttps://doi.org/10.1111/j.1399-0004.1998.tb02745.xopenalex-snapshot
Murine MPS I: insights into the pathogenesis of Hurler syndrome
inferred← citeshttps://doi.org/10.1111/j.1399-0004.2011.01680.xopenalex-snapshot
Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis
inferred← citeshttps://doi.org/10.1111/j.1750-3639.1998.tb00145.xopenalex-snapshot
Mouse Models of Human Lysosomal Diseases
inferred← citeshttps://doi.org/10.1111/jcmm.71396openalex-snapshot
Molecular Dynamics Reveals a Glycan Conformation Underlying IDUA Dysfunction in Attenuated MPS I
inferred← citeshttps://doi.org/10.1136/adc.76.2.92openalex-snapshot
Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres
inferred← citeshttps://doi.org/10.1136/bcr-2016-215416openalex-snapshot
Mucopolysaccharidosis type I disguised as rickets
inferred← citeshttps://doi.org/10.1136/bcr-2017-221156openalex-snapshot
Mucopolysaccharidosis type IVA (Morquio A): a close differential diagnosis of spondylo-epiphyseal dysplasia
inferred← citeshttps://doi.org/10.1136/bcr-2024-264555openalex-snapshot
Mucopolysaccharidosis type IVA (Morquio A) in twins masquerading as distal renal tubular acidosis
inferred← citeshttps://doi.org/10.1136/jmg.34.11.939openalex-snapshot
Mucopolysaccharidosis type I: identification of novel mutations that cause Hurler/Scheie syndrome in Chinese families.
inferred← citeshttps://doi.org/10.1136/jmg.34.2.105openalex-snapshot
Fucosidosis: genetic and biochemical analysis of eight cases.
inferred← citeshttps://doi.org/10.1136/jmg.36.1.28openalex-snapshot
Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel α-N-acetylglucosaminidase gene mutations
inferred← citeshttps://doi.org/10.1136/vetreccr-2015-000274openalex-snapshot
Generalised vertebral abnormalities in a Rhodesian ridgeback with a lysosomal storage disease
inferred← citeshttps://doi.org/10.1146/annurev-med-050715-104432openalex-snapshot
Lysosomal Proteins as a Therapeutic Target in Neurodegeneration
inferred← citeshttps://doi.org/10.1177/088307380201700214openalex-snapshot
Hurler's Syndrome, West's Syndrome, and Vitamin D-Dependent Rickets
inferred← citeshttps://doi.org/10.1186/1746-1596-6-39openalex-snapshot
Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
inferred← citeshttps://doi.org/10.1186/1746-1596-6-47openalex-snapshot
Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients
inferred← citeshttps://doi.org/10.1186/s12864-024-10724-1openalex-snapshot
Mucopolysaccharidosis type I: founder effect of the p.P533R mutation in North Africa
inferred← citeshttps://doi.org/10.1186/s12881-016-0319-xopenalex-snapshot
Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.1186/s12886-020-01689-2openalex-snapshot
Multimodal imaging of Hurler syndrome-related keratopathy treated with deep anterior lamellar keratoplasty
inferred← citeshttps://doi.org/10.1186/s13000-018-0710-3openalex-snapshot
Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome
inferred← citeshttps://doi.org/10.1186/s13023-016-0478-zopenalex-snapshot
Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children
inferred← citeshttps://doi.org/10.1186/s13052-018-0553-2openalex-snapshot
Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know
inferred← citeshttps://doi.org/10.1201/b13564-87openalex-snapshot
Hurler disease/mucopolysaccharidosis type IHa- L-iduronidase deficiency
inferred← citeshttps://doi.org/10.1203/01.pdr.0000141987.69757.ddopenalex-snapshot
Disease-Specific Markers for the Mucopolysaccharidoses
inferred← citeshttps://doi.org/10.14295/rp.v55i4.187openalex-snapshot
Mucopolisacaridosis tipo I, variante síndrome de Hurler: Abordaje inicial y relación con la literatura
inferred← citeshttps://doi.org/10.1517/14712598.2.8.967openalex-snapshot
α-L-Iduronidase and enzyme replacement therapy for mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.1542/peds.2008-0416openalex-snapshot
Mucopolysaccharidosis I: Management and Treatment Guidelines
inferred← citeshttps://doi.org/10.1542/peds.2009-2047openalex-snapshot
Fatal Coronary Artery Disease in an Infant With Severe Mucopolysaccharidosis Type I
inferred← citeshttps://doi.org/10.1586/eem.11.72openalex-snapshot
Laronidase for the treatment of mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.2144/03351dd01openalex-snapshot
Clinical development of therapeutic recombinant proteins
inferred← citeshttps://doi.org/10.2147/btt.s3180openalex-snapshot
α-L-iduronidase therapy for mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.2165/00003495-200767180-00005openalex-snapshot
Treatment of Lysosomal Storage Disorders
inferred← citeshttps://doi.org/10.2165/00063030-200519010-00001openalex-snapshot
Laronidase Treatment of Mucopolysaccharidosis I
inferred← citeshttps://doi.org/10.2478/rrlm-2020-0030openalex-snapshot
Mucopolysaccharidosis type I - Clinical and genetic characteristics of Romanian patients
inferred← citeshttps://doi.org/10.2484/rcr.v7i2.641openalex-snapshot
Mucopolysaccharidosis type I Hurler-Scheie syndrome affecting two sisters
inferred← citeshttps://doi.org/10.31274/etd-180810-308openalex-snapshot
Enzyme replacement therapy treatment from birth increases therapeutic efficacy and generates tolerance to enzyme in canine mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.32708/uutfd.833998openalex-snapshot
Mukopolisakkaridoz Hastalarının Geriye Yönelik Olarak Değerlendirilmesi: Tek Merkez Deneyimi
inferred← citeshttps://doi.org/10.3389/fgene.2024.1377743openalex-snapshot
The top 100 most cited articles on mucopolysaccharidoses: a bibliometric analysis
inferred← citeshttps://doi.org/10.3389/fmolb.2021.783644openalex-snapshot
Mucopolysaccharidosis Type I in the Russian Federation and Other Republics of the Former Soviet Union: Molecular Genetic Analysis and Epidemiology
inferred← citeshttps://doi.org/10.3390/ijms21249449openalex-snapshot
Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches
inferred← citeshttps://doi.org/10.3390/jcm8122190openalex-snapshot
Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders
inferred← citeshttps://doi.org/10.3390/life11111162openalex-snapshot
Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
inferred← citeshttps://doi.org/10.3906/sag-1411-160openalex-snapshot
Evaluation and identification of IDUA gene mutations in Turkishpatients with mucopolysaccharidosis type I
inferred← citeshttps://doi.org/10.4081/cardiogenetics.2013.s1.e2openalex-snapshot
Molecular Basis, Diagnosis and Clinical Management of Mucopolysaccharidoses
inferred← citeshttps://doi.org/10.4103/0976-237x.79287openalex-snapshot
Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report
inferred← citeshttps://doi.org/10.4238/gmr16032602openalex-snapshot
Research Article Clinical features of Mexican patients with Mucopolysaccharidosis type I.
inferred← citeshttps://doi.org/10.46531/sinapse/cc/210086/2022openalex-snapshot
Mucopolysaccharidosis Type I, Hematopoietic Cell Transplantation and Neurodevelopmental Profile: A Case Report
inferred← citeshttps://doi.org/10.5897/ajpp12.134openalex-snapshot
Mucopolysaccharidosis type I: Homology modeling and docking analysis of the lysosomal enzyme, human α-L-iduronidase
inferred← citeshttps://doi.org/10.7439/ijbar.v5i4.683openalex-snapshot
Hurler-Scheie syndrome with subclinical hypothyroidism: A case report
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.